Estrogen-responsive genes overlap with triiodothyronine-responsive genes in a breast carcinoma cell line. 2014

Nancy Bueno Figueiredo, and Sílvia Helena Cestari, and Sandro José Conde, and Renata Azevedo Melo Luvizotto, and Maria Teresa De Sibio, and Denise Perone, and Maria Lúcia Hirata Katayama, and Dirce Maria Carraro, and Helena Paula Brentani, and Maria Mitzi Brentani, and Célia Regina Nogueira
Department of Internal Medicine, Botucatu School of Medicine, University of São Paulo State (UNESP), 18618-000 Botucatu, SP, Brazil.

It has been well established that estrogen plays an important role in the progression and treatment of breast cancer. However, the role of triiodothyronine (T₃) remains controversial. We have previously shown its capacity to stimulate the development of positive estrogen receptor breast carcinoma, induce the expression of genes (PR, TGF-alpha) normally stimulated by estradiol (E₂), and suppress genes (TGF-beta) normally inhibited by E₂. Since T₃ regulates growth hormones, metabolism, and differentiation, it is important to verify its action on other genes normally induced by E₂. Therefore, we used DNA microarrays to compare gene expression patterns in MCF-7 breast adenocarcinoma cells treated with E₂ and T₃. Several genes were modulated by both E₂ and T₃ in MCF-7 cells (Student's t-test, P < 0.05). Specifically, we found eight genes that were differentially expressed after treatment with both E₂ and T₃, including amphiregulin, fibulin 1, claudin 6, pericentriolar material 1, premature ovarian failure 1B, factor for adipocyte differentiation-104, sterile alpha motif domain containing 9, and likely ortholog of rat vacuole membrane protein 1 (fold change > 2.0, pFDR < 0.05). We confirmed our microarray results by real-time PCR. Our findings reveal that certain genes in MCF-7 cells can be regulated by both E₂ and T₃.

UI MeSH Term Description Entries
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014284 Triiodothyronine A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3. Liothyronine,T3 Thyroid Hormone,3,3',5-Triiodothyronine,Cytomel,Liothyronine Sodium,Thyroid Hormone, T3
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D060888 Real-Time Polymerase Chain Reaction Methods used for detecting the amplified DNA products from the polymerase chain reaction as they accumulate instead of at the end of the reaction. Kinetic Polymerase Chain Reaction,Quantitative Real-Time PCR,Quantitative Real-Time Polymerase Chain Reaction,Real-Time PCR,PCR, Quantitative Real-Time,PCR, Real-Time,PCRs, Quantitative Real-Time,PCRs, Real-Time,Quantitative Real Time PCR,Quantitative Real Time Polymerase Chain Reaction,Quantitative Real-Time PCRs,Real Time PCR,Real Time Polymerase Chain Reaction,Real-Time PCR, Quantitative,Real-Time PCRs,Real-Time PCRs, Quantitative
D061986 MCF-7 Cells An estrogen responsive cell line derived from a patient with metastatic human breast ADENOCARCINOMA (at the Michigan Cancer Foundation.) MCF7 Cells,Michigan Cancer Foundation 7 Cells,Cell, MCF-7,Cell, MCF7,Cells, MCF-7,Cells, MCF7,MCF 7 Cells,MCF-7 Cell,MCF7 Cell
D020133 Reverse Transcriptase Polymerase Chain Reaction A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols. Polymerase Chain Reaction, Reverse Transcriptase,Reverse Transcriptase PCR,PCR, Reverse Transcriptase,Transcriptase PCR, Reverse

Related Publications

Nancy Bueno Figueiredo, and Sílvia Helena Cestari, and Sandro José Conde, and Renata Azevedo Melo Luvizotto, and Maria Teresa De Sibio, and Denise Perone, and Maria Lúcia Hirata Katayama, and Dirce Maria Carraro, and Helena Paula Brentani, and Maria Mitzi Brentani, and Célia Regina Nogueira
September 1973, The Journal of biological chemistry,
Nancy Bueno Figueiredo, and Sílvia Helena Cestari, and Sandro José Conde, and Renata Azevedo Melo Luvizotto, and Maria Teresa De Sibio, and Denise Perone, and Maria Lúcia Hirata Katayama, and Dirce Maria Carraro, and Helena Paula Brentani, and Maria Mitzi Brentani, and Célia Regina Nogueira
July 2004, The Journal of steroid biochemistry and molecular biology,
Nancy Bueno Figueiredo, and Sílvia Helena Cestari, and Sandro José Conde, and Renata Azevedo Melo Luvizotto, and Maria Teresa De Sibio, and Denise Perone, and Maria Lúcia Hirata Katayama, and Dirce Maria Carraro, and Helena Paula Brentani, and Maria Mitzi Brentani, and Célia Regina Nogueira
October 2012, BMC systems biology,
Nancy Bueno Figueiredo, and Sílvia Helena Cestari, and Sandro José Conde, and Renata Azevedo Melo Luvizotto, and Maria Teresa De Sibio, and Denise Perone, and Maria Lúcia Hirata Katayama, and Dirce Maria Carraro, and Helena Paula Brentani, and Maria Mitzi Brentani, and Célia Regina Nogueira
July 2014, Epigenetics,
Nancy Bueno Figueiredo, and Sílvia Helena Cestari, and Sandro José Conde, and Renata Azevedo Melo Luvizotto, and Maria Teresa De Sibio, and Denise Perone, and Maria Lúcia Hirata Katayama, and Dirce Maria Carraro, and Helena Paula Brentani, and Maria Mitzi Brentani, and Célia Regina Nogueira
September 1998, Toxicology and applied pharmacology,
Nancy Bueno Figueiredo, and Sílvia Helena Cestari, and Sandro José Conde, and Renata Azevedo Melo Luvizotto, and Maria Teresa De Sibio, and Denise Perone, and Maria Lúcia Hirata Katayama, and Dirce Maria Carraro, and Helena Paula Brentani, and Maria Mitzi Brentani, and Célia Regina Nogueira
July 1990, Cancer research,
Nancy Bueno Figueiredo, and Sílvia Helena Cestari, and Sandro José Conde, and Renata Azevedo Melo Luvizotto, and Maria Teresa De Sibio, and Denise Perone, and Maria Lúcia Hirata Katayama, and Dirce Maria Carraro, and Helena Paula Brentani, and Maria Mitzi Brentani, and Célia Regina Nogueira
February 2013, Hormones & cancer,
Nancy Bueno Figueiredo, and Sílvia Helena Cestari, and Sandro José Conde, and Renata Azevedo Melo Luvizotto, and Maria Teresa De Sibio, and Denise Perone, and Maria Lúcia Hirata Katayama, and Dirce Maria Carraro, and Helena Paula Brentani, and Maria Mitzi Brentani, and Célia Regina Nogueira
November 1986, Nucleic acids research,
Nancy Bueno Figueiredo, and Sílvia Helena Cestari, and Sandro José Conde, and Renata Azevedo Melo Luvizotto, and Maria Teresa De Sibio, and Denise Perone, and Maria Lúcia Hirata Katayama, and Dirce Maria Carraro, and Helena Paula Brentani, and Maria Mitzi Brentani, and Célia Regina Nogueira
January 1998, Cell biology international,
Nancy Bueno Figueiredo, and Sílvia Helena Cestari, and Sandro José Conde, and Renata Azevedo Melo Luvizotto, and Maria Teresa De Sibio, and Denise Perone, and Maria Lúcia Hirata Katayama, and Dirce Maria Carraro, and Helena Paula Brentani, and Maria Mitzi Brentani, and Célia Regina Nogueira
February 1998, Nucleic acids research,
Copied contents to your clipboard!